# A Safety, Efficacy Study of CombiflexOmega Versus SmofKabiven in Patients With Parenteral Nutrition

> **NCT01533766** · PHASE3 · COMPLETED · sponsor: **JW Life Science** · enrollment: 50 (estimated)

## Conditions studied

- Parent

## Interventions

- **DRUG:** CombiflexOmega
- **DRUG:** SmofKabiven

## Key facts

- **NCT ID:** NCT01533766
- **Lead sponsor:** JW Life Science
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2012-01
- **Final completion:** 2012-02
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2013-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01533766

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01533766, "A Safety, Efficacy Study of CombiflexOmega Versus SmofKabiven in Patients With Parenteral Nutrition". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01533766. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*